The maker of the highly addictive narcotic pain killer OxyContin has agreed to pay fines totaling $600 Million for "misbranding" of the drug. The top 3 executives are paying $34.5 Million in fines personally. Purdue Pharma (maker) claimed that because OxyContin was a time-release drug, it had a much lower threat to addiction that "short-acting" competitors such as Percocet. The maker, while filing statements with the FDA that OxyContin was "believed to reduce" addiction, nevertheless marketed the drug to doctors as definitively being an option with less dependency rather than in theory. link.